{"Q": 1, "answer": "no", "rationale": "No intensifier or comparative directly modifies a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_14808", "batch_size": 260, "batch_pos": 11, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 2, "answer": "no", "rationale": "The segment expresses uncertainty ('too early to tell how many doses') without high-potency framing.", "method": "llm_batch", "batch_id": "batch_2_15340", "batch_size": 260, "batch_pos": 256, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 3, "answer": "no", "rationale": "This discusses future capability/uncertainty and lacks a moderate verb + scale of impact.", "method": "llm_batch", "batch_id": "batch_3_15964", "batch_size": 260, "batch_pos": 197, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 4, "answer": "no", "rationale": "The segment does not contain a loaded rhetorical question.", "method": "llm_batch", "batch_id": "batch_4_11928", "batch_size": 260, "batch_pos": 191, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 5, "answer": "no", "rationale": "The segment expresses uncertainty ('too early to tell'), not a calming cue.", "method": "llm_batch", "batch_id": "batch_5_14700", "batch_size": 260, "batch_pos": 188, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 6, "answer": "no", "rationale": "No minimiser + scale contrast found.", "method": "llm_batch", "batch_id": "batch_6_2460", "batch_size": 260, "batch_pos": 151, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 7, "answer": "no", "rationale": "The segment contains 'too early to tell' but not a bare negation about risk/cases/impact.", "method": "llm_batch", "batch_id": "batch_7_16796", "batch_size": 260, "batch_pos": 140, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 8, "answer": "yes", "rationale": "Describes uncertainty about manufacturing capability ('too early to tell how many doses... manufacture') without explicit reassurance.", "method": "llm_batch", "batch_id": "batch_8_6524", "batch_size": 260, "batch_pos": 16, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
